HighCape Capital Acquisition Corp. II (HCCR)

HighCape Capital Acquisition II was planning to go public, but the IPO has been withdrawn.
Stock Price: $10.00
Confirmed IPO price
Chart not available yet
Data will show when the stock starts trading.
Market Cap 256.00M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 25.60M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About HCCR

HighCape Capital Acquisition II is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to focus on industries that complement our management team’s background in life sciences and life sciences related industries, and to capitalize on the ability of our management team to identify and acquire a business within those industries. We intend to focus our investment effort ... [Read more...]

Industry Blank Check / SPAC
Founded 2021
CEO Kevin Rakin
Country United States
Stock Exchange NASDAQ
Ticker Symbol HCCR
Full Company Profile


Life sciences SPAC HighCape Capital Acquisition II files for a $200 million IPO

HighCape Capital Acquisition II, the second blank check company formed by HighCape Capital targeting life sciences, filed on Wednesday with the SEC to raise up to $200 million in an initial public offer...

HighCape Capital Acquisition II IPO Registration Document (S-1)

HighCape Capital Acquisition Corp. II has filed to go public with an IPO on the NASDAQ.